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Abstract
Background: Type 2 diabetes is a serious, pervasive metabolic condition that disproportionately affects ethnic minority patients.
Telehealth interventions can facilitate type 2 diabetes monitoring and prevent secondary complications. However, trials designed
to test the effectiveness of telehealth interventions may underrecruit or exclude ethnic minority patients, with language a potential
barrier to recruitment. The underrepresentation of minorities in trials limits the external validity of the findings for this key patient
demographic.
Objective: This systematic review examines (1) the research reporting practices and prevalence of ethnic minority patients
included in telehealth randomized controlled trials (RCTs) targeting type 2 diabetes and the trial characteristics associated with
recruiting a high proportion of minority patients, and (2) the proportion of included RCTs that report using English language
proficiency as a patient screening criterion and how and why they do so.
Methods: Telehealth RCTs published in refereed journals targeting type 2 diabetes as a primary condition for adults in Western
majority English-speaking countries were included. Ethnically targeted RCTs were excluded from the main review, but were
included in a post hoc subgroup analysis. Abstract and full-text screening, risk of bias assessment, and data extraction were
independently conducted by two reviewers.
Results: Of 3358 records identified in the search, 79 articles comprising 58 RCTs were included. Nearly two-thirds of the RCTs
(38/58) reported on the ethnic composition of participants, with a median proportion of 23.5% patients (range 0%-97.7%). Fourteen
studies (24%) that included at least 30% minority patients were all US-based, predominantly recruited from urban areas, and
described the target population as underserved, financially deprived, or uninsured. Eight of these 14 studies (57%) offered
intervention materials in a language other than English or employed bilingual staff. Half of all identified RCTs (29/58) included
language proficiency as a participant-screening criterion. Language proficiency was operationalized using nonstandardized
measures (eg, having sufficient “verbal fluency”), with only three studies providing reasons for excluding patients on language
grounds.
Conclusions: There was considerable variability across studies in the inclusion of ethnic minority patients in RCTs, with higher
participation rates in countries with legislation to mandate their inclusion (eg, United States) than in those without such legislation
(eg, United Kingdom). Less than 25% of the RCTs recruited a sizeable proportion of ethnic minorities, which raises concerns
about external validity. The lack of objective measures or common procedures for assessing language proficiency across trials
implies that language-related eligibility decisions are often based on trial recruiters’ impressionistic judgments, which could be
subject to bias. The variability and inconsistent reporting on ethnicity and other socioeconomic factors in descriptions of research
participants could be more specifically emphasized in trial reporting guidelines to promote best practice.
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Introduction
Diabetes, a chronic metabolic condition, is on the rise, placing
growing resource pressures on health care systems worldwide
[1]. With the risk of developing diabetes increasing with obesity,
sedentary behavior, and age, type 2 diabetes accounts for
roughly 90% of diabetes cases. Behavioral changes (eg, diet,
exercise), coupled with medication aiming to lower blood sugar
levels and blood pressure, can reduce the risk of developing
diabetes-related complications [2]. Due to its prevalence and
the benefits of effective disease management, type 2 diabetes
is frequently targeted in studies aiming to promote lifestyle
modification through behavioral interventions and education
[3].
Telehealth, broadly defined as remote health care delivery using
technology [4], can partially alleviate the growing pressures
associated with aging populations and rising rates of chronic
conditions [5]. Technological advances have led to the
availability of wide-ranging telehealth options to support patients
as an alternative or supplement to traditional outpatient care,
with presumed benefits including cost reduction, increasing
convenience and access, and promoting patient self-management
[6,7]. For example, diabetes-related telehealth services often
involve platforms for measuring and communicating blood
glucose information and receiving feedback from an automated
system or remote professional. Other services involve structured
self-management education or peer or motivational support [8].
Although findings from randomized controlled trials (RCTs)
testing the effectiveness of telehealth interventions have been
mixed and tend to vary by condition, systematic reviews
focusing on type 2 diabetes specifically have generally yielded
positive results, including modest but significant improvements
for glycemic control and favorable outcomes for patient quality
of life and treatment satisfaction [8-15].
Due to its flexibility, telehealth has the potential to reach
underserved patients who may experience difficulties accessing
traditional health services [16,17]. This extends to ethnic
minorities, who are particularly vulnerable to developing type
2 diabetes [18], tending to do so at a younger age and with a
lower body mass index than the general population in Western
countries [19]. In the United Kingdom, for example, South
Asians have up to six times higher prevalence of type 2 diabetes
compared to people from Caucasian backgrounds, with incidence
up to three times higher in people of African or
African-Caribbean descent [20]. Ethnic minority groups also
experience poorer long-term outcomes for diabetes, such as
worse glycemic control and higher rates of complications [21],
even when patients have access to health care at minimal cost
[22] and after adjusting for age and socioeconomic status
[19,23]. Ethnic minorities may also experience impaired
self-management and underuse services due to a combination
of socioeducational factors, including a less developed
understanding of diabetes, differing attitudes toward medication,
culturally specific dietary practices, and/or language barriers to
accessing care [13,24,25].
Despite having a higher incidence of diabetes, ethnic minority
patients tend to be underrepresented in trials [26-28]. This means
that they cannot receive the potential health benefits from trial
participation [29,30], including access to improved treatments
and closer monitoring during the trial period. In addition, studies
are not able to adequately assess the effectiveness of new
treatments for these higher-need groups. For example, telehealth
technologies trialed on a disproportionately Caucasian sample
may not be generalizable to a diverse patient demographic, with
implications for the service-level adoption of such interventions
[31,32]. Low participation rates of ethnic minority diabetes
patients have been reported in systematic reviews focusing on
telehealth interventions, although the ethnic composition of the
recruited sample is often unreported. In a 2006 review, only
eight of 26 included studies reported on the ethnic composition
of trial participants, of which the median proportion of ethnic
minority patients was 39% (range 5%-100%) [33]. Similarly,
two 2014 reviews found that only half of 16 included studies
[34] and four of nine included studies [3] reported on the ethnic
makeup of the recruited sample, with variable minority
participation across these studies (range 15%-100% and range
24%-100% of total participant population, respectively).
Although the results of these reviews [3,33,34] are revealing in
terms of prevalence and research reporting practices, they have
several limitations. First, the included studies were restricted to
a narrow range of computer-based telehealth interventions—a
subset of the wide variety of the telehealth technologies
available. For example, they excluded trials that were
phone-based or included glucose monitoring, which are
pervasive in telehealth diabetes research [15]. Next, two reviews
included studies that targeted both type 1 and type 2 diabetes
[33,34]. Because ethnic minorities are not disproportionately
affected by type 1 diabetes, it is important to identify the
prevalence of minority participants in studies that exclusively
focus on type 2 diabetes. Third, two of the reviews included
trial designs other than RCTs [3,33], with different designs
potentially affecting the type of patients who had opted to take
part (eg, due to time commitments) [35,36] in addition to not
providing the same design safeguards against bias [37]. Finally,
both 2014 reviews included studies that specifically recruited
from one or more ethnic minority communities [3,34]. The
J Med Internet Res 2016 | vol. 18 | iss. 9 | e256 | p.2http://www.jmir.org/2016/9/e256/
(page number not for citation purposes)
Isaacs et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
inclusion of these ethnically targeted studies likely inflated
ethnic minority patient prevalence estimates relative to studies
recruiting from the general population. This systematic review
addresses these limitations by focusing on telehealth RCTs
targeting type 2 diabetes in adults recruited from the wider
patient population. The telehealth medium used in the RCTs
was not restricted in order to more comprehensively survey
research reporting practices across the range of technologies.
A central aim of this review was to explore the barriers and
facilitators to ethnic minority inclusion in telehealth RCTs.
Among the factors that could affect ethnic minority participation
in RCTs, language and literacy are often identified as potential
obstacles [26,31]. Of foreign-born people living in the United
States, 29% reported speaking English “not well” or “not at all”
[38] compared to more than 12% in Australia [39]. In England
and Wales, nearly 19% of adults from the four largest ethnic
minority communities were estimated to speak little or no
English [40]. Poor language skills are also related to higher
levels of undiagnosed diabetes and to difficulties accessing
services [13,41]. Ensuring that patients have the requisite
language ability to understand the conditions for trial
participation is an ethical imperative in all research (eg,
obtaining informed consent). Because communication is a key
part of the treatment in telehealth trials, language could act as
a barrier to telehealth’s ability to provide more accessible,
equitable modalities for delivering care. For example, telehealth
interventions often necessitate basic literacy skills (eg,
understanding and inputting written text) or enhanced
communication skills (eg, communicating on the phone with
no access to nonverbal cues), potentially barring the participation
of patients without adequate language skills to engage with the
intervention in the absence of translation or interpretation
services [42].
There is a pressing need to examine the role of language in
telehealth interventions, especially in countries where a sizeable
portion of the population has limited ability in the official
language. This is particularly the case for conditions such as
type 2 diabetes, to which ethnic minority communities are
particularly vulnerable. Yet little is known about whether and
how patients are screened for language proficiency or literacy
nor the extent to which these factors are cited among the
participant inclusion or exclusion criteria in telehealth RCTs
targeting type 2 diabetes [30,43]. In light of these gaps, the goals
of this systematic review were to investigate (1) the research
reporting practices and prevalence of ethnic minority patients
included in telehealth RCTs targeting type 2 diabetes and trial
characteristics associated with successful minority patient
recruitment, and (2) the proportion of included RCTs that report
English language proficiency as a participant-screening criterion
and how and why proficiency was assessed.
Methods
This review followed the Cochrane Collaboration’s handbook
on conducting systematic reviews [44] and the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [45]. Full methodological details,
including MEDLINE search strategy terms, are reported in the
published protocol [46].
Search Strategy and Study Screening and Selection
The search, which was conducted in late August 2015, included
studies published from January 1, 2000 to July 31, 2015 using
MEDLINE, PsycINFO, EMBASE, CINAHL, and CENTRAL.
Keywords and inclusion criteria from recent related reviews
were examined [15,34,47,48] and a medical librarian was
consulted to verify the search strategy (eg, keywords, choice of
databases). Abstract and full-text screening were independently
performed by two reviewers (LE, KB, or DW), with
discrepancies resolved through discussion. Multiple outputs
from the same dataset were linked for included studies and
imported into Endnote X7.
Included studies were peer-reviewed English-language journal
articles on telehealth RCTs recruiting adult (≥18 years) type 2
diabetes patients from Western countries where English is both
an official and the majority language (ie, Australia, Canada,
Ireland, New Zealand, United Kingdom, United States). All
other research designs and publication types were excluded, as
were RCTs that included type 1 or gestational diabetes patients,
or that had explicitly targeted one or more ethnic minority
groups in their recruitment strategy. Interventions could
comprise any telehealth medium designed to treat or improve
type 2 diabetes as the primary condition. Studies focusing on
secondary diabetes-related complications (eg, retinopathy) or
mental health were excluded as were telehealth interventions
solely targeting health professionals rather than patients.
Data Collection
The data extraction form Multimedia Appendix 1 was developed
using Cochrane guidelines [44] to describe study details,
participant demographics, and intervention characteristics.
Outcome data were extracted using Microsoft Excel and
independently checked by two reviewers (DH, DW). The
Cochrane Collaboration’s risk of bias (ROB) tool [49] was
adapted to assess all 79 included articles using Cochrane’s
Review Manager software (RevMan, The Cochrane
Collaboration, Copenhagen, Denmark). Two of three authors
(LE, DH, DW) independently evaluated each article for low,
unclear, or high ROB, with discrepancies resolved through
discussion. The assessment criteria were random sequence
generation (selection bias), allocation concealment (selection
bias), blinding of participants and personnel (performance bias),
blinding of outcome assessment (detection bias), incomplete
outcome data (attrition bias), selective reporting (reporting bias),
and other sources of bias (other bias).
Due to the nature of telehealth interventions, patient and
personnel blinding is generally unfeasible. Hence, for the
purpose of this review, high risk of performance bias was
interpreted as situations where unblinded research personnel
interacted with participants across study groups, allowing for
differential treatment. Assessment of detection bias focused on
primary outcome detection. Studies that used an objective
primary outcome measure (eg, laboratory-based blood test,
administrative record of number of hospital visits) were assessed
as low ROB because knowledge of participants’ allocation is
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unlikely to seriously affect the outcome. Conversely, studies
where the primary outcome was subjectively assessed (eg,
self-report measures) were deemed high ROB.
Data Analysis
Data analysis of included studies addressed the following
primary outcomes:
1. Proportion of studies that report on the ethnic composition
of recruited participants and, where available, the overall
prevalence of ethnic minority patients (between-study median
and range);
2. Characteristics of studies that recruit a high proportion (≥30%)
of ethnic minority participants (eg, telehealth medium, access
to translation);
3. Proportion of studies that include English language
proficiency or reading and writing literacy as a
participant-screening criterion and, where available, the ways
in which proficiency/print literacy is operationalized as a
screening criterion; and
4. Language-related reasons for patient exclusion, if given (eg,
informed consent, lack of resources).
In line with categorizations of race and ethnicity in the United
States census [50] and conceptualizations of nonwhite or
non-Caucasian respondents in other majority English-speaking
countries (eg, United Kingdom [51]), ethnic minorities were
defined as those of nonwhite ethnicity, including Hispanics,
who may or may not be newcomers to the host country. In the
case of studies reporting only the proportion of white patients
recruited, all other participants were assumed to be ethnic
minorities. In other studies that listed the proportion of
participants belonging to an “other” group, “other” was
interpreted as patients from an ethnic minority background not
specified elsewhere in the study.
A narrative synthesis [52] was conducted to examine the
characteristics of RCTs that reported a 30% or greater threshold
of ethnic minority participants as a proportion of the total sample
(considered relatively high), which is in line with the median
prevalence of minority recruitment reported in earlier related
reviews [3,33,34]. We would also note that this threshold is
close to the proportion of ethnic minorities in the United States
population. In the 2015 census, the “white alone, not Hispanic
or Latino” category was reported at 61.6%, which implies that
the remaining 38.4% are ethnic minorities [53]. After
systematically extracting and tabulating the data, groupings and
textual descriptions were used to explore heterogeneity within
those studies and between studies with higher and lower
proportions of ethnic minority participants. Exploration of
relationships in the data was iteratively conducted to reveal
factors that may promote or impede ethnic minority recruitment.
Finally, a post hoc subgroup analysis was conducted for studies
that had explicitly targeted one or more ethnic minority groups
as part of their recruitment strategy and that had been excluded
from the systematic review for that reason only [54-65]. This
additional retrospective analysis of ethnically targeted studies
was undertaken to further examine recruitment strategies and
features of trials that specifically recruited ethnic minority
participants. This analysis involved the same methods as the
synthesis described previously, but did not contribute to
calculations reported in the main analysis.
Results
Study Selection
The search yielded 2332 records after removing duplicates,
which were submitted to abstract screening. After assessing 212
full-length articles for eligibility, 79 articles, consisting of 58
discrete RCTs, met the inclusion criteria (see Figure 1).
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram summarizing the process of selecting eligible
studies for the systematic review. RCT: randomized controlled trial, T2DM: type 2 diabetes.
Characteristics of Included Studies
Multimedia Appendix 2 summarizes the characteristics of
included studies in the review. The total number of participants
across included RCTs was 12,916, with sample sizes ranging
from 14 to 1665 (median 160). Nearly three-quarters (43/58)
were recruited from the United States, whereas the rest were
carried out in Australia (5/58), Canada (5/58), the United
Kingdom (4/58), and one in both the United States and Canada.
The studies involved a wide range of telehealth media and
devices, the most popular of which was phone-based telehealth
interventions. Other frequently used telehealth tools included
Internet technologies (eg, static and interactive webpages, email,
instant messaging), computerized self-management programs,
and glucose meters integrated with mobile apps. Several studies
combined different media and communication types as part of
the intervention, including electronic medical records,
educational websites, home monitoring, and videoconferencing
(eg, [66]).
Methodological Quality
Parts A and B of Multimedia Appendix 3 show the ROB
summary table and graph for included studies. Of the 79 articles,
34 described an appropriate randomization procedure, two
[67,68] reported inadequate randomization, and the remainder
provided insufficient detail for assessing risk of selection bias
(judged unclear). Similarly, allocation concealment reporting
was frequently insufficient to determine the ROB (eg, not clear
whether allocation envelopes were opaque and sequentially
numbered [69]). Most studies reported designs intended to
reduce performance bias (within the parameters of unfeasible
patient and interventionist blinding), with studies judged as
having a high ROB in cases when nonblinded staff delivered
both the telehealth intervention and usual care [69-83] and also
collected follow-up measures [84,85]. Included studies employed
both subjective and objective outcome measures, with objective
glycated hemoglobin (HbA1c) levels being the most common
primary outcome. Approximately half of the studies included
patient attrition information, with unclear ROB assigned when
reasons for attrition were not given, attrition was not broken
down by group allocation, or it was unclear how substantial
missing data were dealt with in data analysis. Several studies
were assessed as having a high ROB due to a large difference
in attrition between study arms that was attributed to the
intervention [86,87] or that had only presented outcomes for
patients who had completed the intervention and/or all follow-up
measures [88-91]. There was generally a low risk of reporting
bias, with most studies reporting on prespecified outcomes. A
high ROB was noted in studies where reported outcomes
deviated from the protocol or specified methodologies
[70,85,91-97] or insufficiently reported statistical or summary
data [67,68,71,72,83,98-105]. Most studies were free of other
sources of bias. However, some failed to report treatment dosage
(eg, frequency of calls [74,90,106,107]) and its effect on
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outcomes even when adherence was low. Others were pilot
studies or had small convenience samples, limiting their
generalizability [71,85,95,101,108,109].
Ethnic Minority Participation
Thirty-eight of the 58 included RCTs (or 56 of the 79 articles)
provided information on the ethnic composition of the sample
[66-78,80,85,87,89,91-98,100-130], of which the median
proportion of ethnic minority participants was 23.5% (range
0%-97.7%). Two of these recruited no ethnic minority patients
[71,77]. The remaining studies (n = 20) provided no ethnicity
information, including all five Canadian studies
[79,81-84,86,88,90,99,131-144]. Figure 2 shows that the number
of included studies in the review markedly increased after 2005,
with eight up until that year and 50 thereafter. The proportion
of the studies that reported on the ethnicity of recruited patients
was 38% (3/8) up to and including 2005 and more than doubled
to 70% (35/50) after that date.
Figure 2. Number of included studies (n=58) reporting on the ethnic composition of the recruited sample by year of publication.
Language Proficiency
Half of the included RCTs (29/58) reported English language
proficiency as a patient inclusion or exclusion criterion, with
six of these studies alternatively requiring proficiency in Spanish
[66,94,105,106,110,111] and one in either Spanish or Cantonese
instead of English [118]. In the 29 remaining RCTs, language
ability may have been considered in recruitment but not reported
in the published article, including one study that did not list any
screening criteria at all [72]. Alternatively, language might not
have been taken into account in recruitment. Although being
able to engage with the intervention may be an implicit reason
for including language as an eligibility criterion, only three
studies provided explicit explanations for excluding prospective
participants on language grounds. In two, this pertained to
understanding study information and providing informed consent
[99,109]. In the third, this related to language demands required
for the intervention, which involved patients receiving tailored
feedback through an automated interactive phone service [142].
Of the studies that included language proficiency as an eligibility
criterion, there was little consistency in the way that this was
defined. More than a third (11/29) emphasized being able to
communicate in or fluently speak (and in two cases also
understand) English, whereas another specified language without
reference to the written medium. Of these, two studies further
specified that the context for this was over the phone [91,142],
which is more difficult than face-to-face communication [42].
Four other studies referred to participants needing to be able to
read and speak English, seven required reading and writing, and
two referred to reading and understanding (ie, receptive skills),
placing no apparent emphasis on speaking or writing. Finally,
five studies emphasized having English (or Spanish) as a main
or primary language, implying that membership to the target
language community (ie, native speaker status) was the key
criterion.
From these descriptions, there were no indications that any
objective measures (eg, temporal measures of fluency or oral
comprehension questions) were used to establish whether
prospective participants had the necessary skills to meet the
specified language criterion for inclusion in the study. Reference
to commonly used benchmarks of language proficiency or
defined levels (eg, Canadian Language Benchmarks, Common
European Framework of Reference for Languages) were not
given [145]. The grounds on which a patient was determined
to be linguistically eligible to participate were also unspecified.
Two studies administered previously validated health literacy
instruments to patients [75,118]. However, this was used to
assess study outcomes in relation to health literacy and there
was no threshold health literacy level required for participation.
In sum, there were no explicit or standardized measures of
language proficiency across included studies—a variable which
could directly affect the ethnic minority patient participation
[146].
Narrative Synthesis
Of the 79 articles reporting on 14 distinct RCTs, 28 recruited a
high proportion of ethnic minority patients, with the threshold
for this set at 30% or greater (median 53.3%, range
30.0%-97.7%; see Table 1) [66,70,75,85, 87,94,103,105,106,
110,111,116, 118,119]. They all took place in the United States,
mostly in urban settings, with only one study exclusively
recruiting from a rural setting [70]. These studies frequently
recruited in medically underserved and financially deprived
areas [66,70,106,110,111] and described their target populations
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as predominantly uninsured [75,106,111,118]. In addition to
including ethnic minorities, these studies also had high numbers
of patients with no insurance or who received
government-sponsored Medicare or Medicaid benefits. For
example, of the three studies recruiting patients from safety-net
clinics, which treat uninsured patients, more than 89% were
nonwhite [75,110,118]. Two studies required health care
coverage as a patient screening criterion [87,103] and one solely
recruited low paid health care worker union members insured
through their employer [105].
Table 1. Summary of characteristics of 14 parent studies with a high proportion (≥30%) of ethnic minority patients.
Tailoring of interventioncBenefits of participa-
tionb
Setting and patient characteristicsaInterventionStudy
LiteracyCulturalBilingualDeviceFinancialUnderservedUrban onlyRecruit-
ment
Telehealth medium
YesYesYesYesYesPCPhoneAnderson et al
[106]
YesYesYesYesYesYesSNMobile SMSArora et al [110]
YesYesYesYesRuralPCVideoconference &
pedometer
Davis et al [70]
YesYesYesPC ComVideo & phoneFrosch et al [111]
YesYesYesPCWebsite & phone (au-
tomated & from an in-
terventionist)
Glasgow et al
[94]
YesYesYesYesYesSNComputer multimedia
education
Khan et al [75]
YesPCPhoneKrein et al [116]
YesMixedPC ComBluetooth blood glu-
cose meter with mo-
bile app
Quinn et al [85]
YesMixedPCMobile SMS, patient
portal & phone
Quinn et al [87]
YesYesYesYesYesSNPhoneSchillinger et al
[118]
YesYesYesComPersonal digital assis-
tant
Sevick et al [119]
YesYesYesYesMixedPCWebsite, videoconfer-
ence, electronic
records & email
Shea et al [66]
YesYesPCBluetooth blood glu-
cose meter & electron-
ic records
Tang et al [103]
YesYesYesUnionPhoneWalker et al
[105]
a Recruitment: Description of setting from which participants were recruited; PC: primary care; SN: safety net; Com: community center; Union: health
care workers’ union. Urban only: refers to recruitment solely from urban areas. All mixed studies recruited from both urban and rural areas, with the
exception of [85], which recruited from urban and suburban areas. Underserved: medically underserved/uninsured/low-wage patients or Medicare/Medicaid
beneficiaries.
b Financial: monetary incentives for research participation, including money, gift cards, or vouchers. Device: provision of technology or equipment
including self-monitoring devices used in the intervention.
c Bilingual: recruitment or educational materials translated into a minority language or availability of bilingual interventionists. Cultural: materials
crafted for or through consultation with members from certain minority communities independent of language. Literacy: materials purposefully written
at a particular grade level or staff trained to communicate with low-literacy patients.
High minority-recruiting studies used a mix of telehealth
delivery modes, reflecting the breadth of technology used in
the wider sample of studies included in the review. This suggests
that the medium through which a telehealth intervention is
delivered has little bearing on ethnic minority recruitment. In
total, 36% (5/14) of the studies offered financial compensation
for trial participation, with money or vouchers ranging from US
$15 to US $175 per participant [70,106,110,118,119]. By
comparison, only 21% (5/24) of low-recruiting studies (<30%
ethnic minorities) offered financial incentives. A proportionately
higher number of high minority-recruiting trials (35.7% vs 21%
in low-recruiting studies) also offered patients equipment to
facilitate self-monitoring, such as glucose meters and/or blood
testing strips, which can impose a substantial cost to patients
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not covered by insurance [70,106,110,118,119], or free mobile
phones if they were being used as part of the intervention
[85,87,103].
Another key characteristic of high minority-recruiting studies
was an emphasis on languages other than English. More than
half (8/14) offered the intervention in a language other than
English, including the use of bilingual staff for phone
interventions [66,75,94,105,106,110,111,118], and two
additionally reported using bilingual recruitment staff or
translated study information to facilitate the recruitment of
nonnative-English-speaking patients [94,118]. Conversely, no
study with less than 30% ethnic minority participants offered
bilingual interventions (see Multimedia Appendix 2). Four
studies reported tailoring intervention materials to the needs
and interests of African American and/or Latino patients, such
as the use of video testimonials from community members
[70,75,94,110], and nearly half reported writing study materials
to facilitate low-literacy patients’ comprehension
[66,70,75,106,110,118].
Post Hoc Subgroup Analysis
A post hoc subgroup analysis was conducted for 12 articles
comprising 11 RCTs that had been excluded during full-text
screening [54-65]. The findings echoed those of the narrative
synthesis (see Table 2). All ethnically targeted studies took
place in urban American settings, with nearly half (5/11)
reportedly recruiting from economically deprived or medically
underserved areas [56,57,60,61,65]. More than half (6/11) used
phone calls as part of the intervention, although other telehealth
media were also used. Although only one study offered patients
intervention-related equipment (laptop and telehealth
peripherals) [57], six offered financial remuneration ranging
from US $40 to US $60 cash or vouchers [55,59,61-63,65], with
one trial additionally offering some patients up to US $200 for
reducing their HbA1c levels by a prespecified amount [62]. The
ethnically targeted studies frequently reported tailoring
interventions to their target demographic, including offering
written and spoken aspects of the intervention in a language
other than English [56,61,64,65], designing interventions
through consultation and feedback from minority groups
[55-58,60,65], and using interventionists drawn from the target
cultural communities [55,61,64,65]. This latter point included
building input from minorities into the recruitment strategy
and/or piloting materials and procedures with them.
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Table 2. Summary of characteristics of 11 ethnically targeted studies subjected to a post hoc subgroup analysis.
Tailoring of interventioncIncentivesbSetting and patient characteristicsaInterventionStudy
LiteracyCulturalBilingualFinancialUnderservedRecruited group(s)Recruit-
ment
Telehealth medium
YesYesYesOlder African
American women
PC comPhoneAmoako &
Skelly [55]
YesYesYesYesSpanish speakersPCVideoCalderón et al
[56]
YesYesAfrican AmericansPCLaptop with home
monitoring, videocon-
ference & electronic
records
Carter et al [57]
YesYesAfrican AmericansPCPhoneCrowley et al
[58]
YesAfrican Americans
& Hispanics
PCPersonal digital assis-
tant
Forjuoh et al
[59]; Adepoju
et al [54]d
YesYesAfrican AmericansPCPhoneGary et al [60]
YesYesYesYesYesAfrican Americans
& Hispanics
ComTablet computerHeisler et al
[61]
YesAfrican American
veterans
PCPhoneLong et al [62]
YesYesSpanish speakersComPhoneLorig et al [64]
YesAmerican Indians/
Alaska Natives
WebWebsiteLorig et al [63]
YesYesYesYesYesAfrican Americans
& Hispanics
PCPhoneRuggiero et al
[65]
a Recruitment: Description of setting from which participants were recruited; PC: primary care; com: community center; Web: website. Recruited
group(s): ethnicities targeted in recruitment and age group, gender, or profession of targeted participants where specified. Underserved: medically
underserved/uninsured/low-wage patients or Medicare/Medicaid beneficiaries.
b Financial: monetary incentives for research participation, including money or vouchers. Bilingual: recruitment or educational materials translated into
a minority language or availability of bilingual interventionists.
c Cultural: materials crafted for or through consultation with members from certain minority communities independent of language, or staff undertook
cultural sensitivity training. Literacy: materials purposefully written at a particular grade level or staff trained to communicate with low-literacy patients.
d These linked articles reported on the same RCT and it was unclear which was the parent study.
Discussion
Principal Findings
This systematic review investigated research reporting practices
and prevalence estimates of ethnic minority participation in
telehealth diabetes RCTs, extending previous reviews by
including a broader range of telehealth technologies targeting
type 2 diabetes. Nearly 66% of included studies reported on the
ethnic composition of their samples. Although this proportion
is higher than in previous reviews [3,33,34], it confirms the
underreporting of ethnicity in peer-reviewed journal articles.
However, compared to the 2006 review that had also excluded
studies recruiting participants from a single ethnic minority
background [33], these results yielded lower median
participation of ethnic minority patients as a proportion of the
total sample (23.5% vs 39%).
All RCTs with 30% or greater ethnic minority recruitment were
US-based, mostly recruited from urban areas, and frequently
described recruited patients as low-income, socially deprived,
or with little or no health care coverage. Participant remuneration
or free telehealth monitoring devices incentivized participation
in nearly 60% of these studies. Although the United States has
a high proportion of ethnic minorities compared to other
countries included in the review [147], its dominance as the
setting for all studies meeting the 30% or greater cut-off for the
narrative review and for all ethnically targeted studies in the
post hoc subgroup analysis suggests that the American National
Institutes of Health (NIH) Policy and Guidelines on the
Inclusion of Women and Minorities as Subjects in Clinical
Research [148] has been influential in promoting minority
representation in trials. Overall, minority participation rates tend
to be higher in the United States, which has legislation to
mandate their inclusion, than in contexts where no such
legislation exists (eg, United Kingdom) [26]. The availability
of trial materials in multiple languages was also a recurrent
feature of studies recruiting substantial numbers of ethnic
minority participants and often occurred in conjunction with
trial materials that accounted for cultural factors or presumed
literacy levels. This suggests that having a language concordant
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interventionist and embedding input from members of target
communities into trial materials could have positive effects on
the recruitment of groups who may otherwise be
underrepresented [149,150]. This supports existing research on
strategies to optimize the recruitment of underserved patients,
which reveals ways of working holistically to alleviate individual
and external factors that impede participation [146,151]. The
emphasis on patient and public involvement in research aligns
with such practices [29,152].
Half of the included studies listed language proficiency among
the patient eligibility criteria, although less than 5% provided
a reason for including or excluding patients on this basis. The
role of language in participant screening was described in
different ways across studies, with emphasis either placed on
different combinations of skills (speaking, listening, reading,
writing) to reflect the nature of the intervention, or on patients’
status as primary speakers of English or another language where
offered. There was no evidence of the use of objective measures
or instruments or of a common procedure across studies to assess
whether patients had the requisite language proficiency to
participate and, in individual studies, this level of detail was not
given. Thus, it was unclear how language-related determinations
about inclusion or exclusion were made—that is, how the
language-screening criterion as stated was operationalized in
arriving at eligibility decisions.
Limitations
This review has several limitations. First, only English-language
articles that recruited patients from Western countries where
English is both an official and the dominant language were
considered. Findings may be different in reviews focusing on
recruitment from other contexts or on other world languages.
Second, ethnic minorities are not a monolith, and language
barriers to engaging with the intervention are likely to be
different for newcomers to a country (eg, migrants), who may
have little knowledge of English, than for later generations of
native English speakers who are visible minorities (eg, African
Americans in the United States) [24]. It is often difficult to
disentangle ethnicity from language in secondary data analysis
because the language background of participants (ie, proportion
of native English speakers and heritage language speakers) is
often not reported as a separate category and, in some countries,
is not captured in census data [40]. Third, and related to this,
we used the ethnicity categories reported in the original studies
in data extraction. However, race and ethnicity are complex
constructs that frequently conflate social identity with other
factors, such as genetic or biological characteristics (particularly
as connoted in the former term), geographical origin, cultural
practices, or religious persuasion [31]. Categorizations were
inconsistent across studies included in this review, making
comparisons between and within countries difficult. Fourth, the
prevalence of minority patients in the area(s) from which they
were recruited was not possible to collate, with several studies
recruiting from different geographic sites and not reporting on
local population or, in some cases, on the ethnic breakdown of
their recruited sample. Finally, peer-reviewed articles were the
sole publication type considered in this study, which was
consistent with the goal of elucidating research reporting
practices in academic journals. That is, the grey literature was
not examined and study authors were not contacted to provide
further information than was included in their published articles,
taking into account linked publications. The brief descriptions
of study setting, design, and recruitment in the included
telehealth RCTs provided comparatively little qualitative data
for the narrative synthesis. This has resulted in a relatively
simple theoretical account of the trial features supporting ethnic
minority participation, which would need to be corroborated
through a more in-depth examination of key variables in
subsequent research. Nonetheless, with 79 articles and 58 RCTs
included, this review is comprehensive in its account of research
reporting and includes more studies than the three previous
telehealth diabetes reviews combined [3,33,34].
Concluding Remarks
Despite the link between new technologies and improved
outcomes, mixed evidence regarding reducing disparities from
the research literature [122,129] suggests that telehealth has yet
to fulfill its potential of being truly accessible to and effective
for ethnic minority diabetes patients [15]. Cultural and linguistic
tailoring to a diverse demographic and offering translation and
interpretation services where possible could extend the benefits
of telehealth type 2 diabetes interventions to a wider
cross-section of patients, thereby promoting more equitable
access to health care [43,153].
Findings from this and earlier systematic reviews suggest that
between a third and half of telehealth diabetes trials provide no
information on the ethnic composition of their samples. Further,
other demographic characteristics, such as socioeconomic status,
are not consistently reported across studies (see Multimedia
Appendix 2). Providing data on participants’ gender and age,
but no information on ethnicity for either the sample or the local
target population is insufficient for assessing the external validity
of the findings. Ethnicity information is necessary to evaluate
claims about telehealth’s accessibility to all patients (and not
just a subsection of the population), including its ability to foster
social inclusion through the uptake of services.
The Consolidated Standards of Reporting Trials (CONSORT)
statement [154], which articulates guidelines for best practice
in research reporting and which has been widely adopted,
advocates reporting baseline demographic and clinical
characteristics for each group in the RCT. However, this is
prefaced on the assumption that these will be collected, and the
statement does not specify which baseline variables should be
captured and described. In the case of clinical baseline variables,
further specification of which variables to target would appear
to be dependent on the nature of the condition being examined
(eg, HbA1c for diabetes). However, this is not the case for
sociodemographic variables, which apply regardless of the
disease type being investigated. In trials targeting chronic
conditions in which prevalence is known to vary by ethnicity
and other social factors, further specification of the baseline
demographic characteristics that should be reported on could
reduce the variability in between-study reporting. This would
assist in examining crucial relationships between
sociodemographic variables and health outcomes. Journal editors
and editorial boards could converge on the most important
sociodemographic characteristics that should be reported (eg,
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in a checklist) to achieve greater consistency and help streamline
such information across studies.
Finally, the fact that telehealth trials seek to recruit patients with
an adequate level of language ability is understandable—
telehealth interventions rely on effective spoken or written
communication as a key part of the “treatment.” However, the
absence of an objective or standardized measure for assessing
whether patients have the requisite language ability to
successfully engage with the intervention suggests that such
decisions are likely being made on the basis of trial recruiters’
subjective judgments. This creates a risk of selection bias, as
trial recruiters might exclude ethnic minority participants based
on the subjective view that they will not be able to adequately
take part in the intervention, despite actually having sufficient
language proficiency [43]. For example, recruiters may misjudge
having a perceptible foreign accent as evidence of poor language
ability in instances when this does not actually impede
communication [155,156]. Conversely, including patients who
do not understand the nature of the intervention due to language
barriers is problematic, not least for ethical reasons [157]. Future
research could focus on the development and validation of a
tool to provide trial recruiters with a simple, practical means of
assessing language proficiency for trial participation to minimize
the possibility of patients being unfairly excluded based on
arbitrary judgments.
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